Fig. 2. As a follow-up flow of the patient, medication was administered if overt hypothyroidism or subclinical hypothyroidism with obvious symptoms occurred.

Int J Thyroidol 2023;16:120-7 https://doi.org/10.11106/ijt.2023.16.1.120

© 2023 Int J Thyroidol